10 results
10-K
2021 FY
ABOS
Acumen Pharmaceuticals Inc
28 Mar 22
Annual report
4:51pm
prevails in a patent infringement lawsuit against us, we may have to stop making and selling the infringing product, pay substantial damages, including
10-Q
2021 Q2
ABOS
Acumen Pharmaceuticals Inc
16 Aug 21
Quarterly report
4:51pm
to continue our operations.
If a third party prevails in a patent infringement lawsuit against us, we may have to stop making and selling the infringing
424B4
oxl mm42js
2 Jul 21
Prospectus supplement with pricing info
4:09pm
S-1/A
pvxbt5sw41qv az3
24 Jun 21
IPO registration (amended)
8:17am
S-1
9ftha
9 Jun 21
IPO registration
5:02pm
DRS/A
8q6b9detrb9sbl
14 May 21
Draft registration statement (amended)
12:00am
DRS
6pvg8b7749
12 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next